PMID: 8609544Jul 1, 1995Paper

Aspects of the epidemiology of MRSA in Europe

Journal of Chemotherapy
B Cookson

Abstract

The prevalence of methicillin-resistant Staphylococcus aureus (MRSA) varies in different European countries, in different cities in the same country or even within a city or a hospital. It is thought that the overall incidence of MRSA is higher than ever before, although the reasons for this are unclear. MRSA typing can identify epidemic MRSA in many countries. The spread of a closely related clone is Northern Europe is a cause for concern, as it is resistant to many agents. In the UK, control measures are threatened by changing patterns of health care and patient demography. Resistance to mupirocin, a valuable agent in the control of MRSA, has emerged in many hospitals in the UK, thus the agent must be used judiciously.

Related Concepts

Related Feeds

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.